UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040534
Receipt number R000046271
Scientific Title IoT-based observation of fluctuated hearing loss and balance disorders
Date of disclosure of the study information 2020/06/30
Last modified on 2020/05/27 03:35:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

IoT-based observation of fluctuated hearing loss and balance disorders

Acronym

IoT-based observation of fluctuated deafness and balance disorders

Scientific Title

IoT-based observation of fluctuated hearing loss and balance disorders

Scientific Title:Acronym

IoT-based observation of fluctuated hearing loss and balance disorders

Region

Japan


Condition

Condition

hearing loss and balance disorders

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to conduct daily hearing tests and perturbation tests for inner ear disorders (hearing loss and balance disorder: both are often combined) to be examined by an otolaryngologist and observe continuous changes in symptoms at home.

Basic objectives2

Others

Basic objectives -Others

Diseases where daily observation are useful and their fluctuation patterns.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Daily hearing and balance data including their fluctuations.

Key secondary outcomes

Relationship between the above fluctuations, diagnosis of each disease, and case information other than inner ear function obtained from medical records


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Daily hearing and balance tests

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

7 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Outpatients of Keio University Hospital Otolaryngology who has an inner ear disorder and is consenting to the study

Key exclusion criteria

- Those who have not agreed to participate in the research. Or if you withdraw your consent.
- Persons who are considered unsuitable for this study by the co-investigators or the representatives based on their medical history such as mental illness and cognitive decline.
- A person who is judged by the research coordinator or the representative that the handling of the measured data is not fully understood.
- The target age is not specified, but if the research coordinator or the representative judges that it is difficult to measure at home using a device, such as children or the elderly, it will be excluded from the target.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Masato
Middle name
Last name Fujioka

Organization

Keio University

Division name

Department of Otorhinolaryngology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku. Tokyo Japan

TEL

03-5363-3827

Email

ent-group@keio.jp


Public contact

Name of contact person

1st name Masato
Middle name
Last name Fujioka

Organization

Keio University

Division name

Department of Otorhinolaryngology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku. Tokyo Japan

TEL

03-5363-3827

Homepage URL


Email

ent-group@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio Center for Clinical Research

Address

35 Shinanomachi, Shinjuku. Tokyo Japan

Tel

03-3353-1211

Email

keio@esct.bvits.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 05 Month 25 Day

Date of IRB


Anticipated trial start date

2020 Year 07 Month 27 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 05 Month 27 Day

Last modified on

2020 Year 05 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046271


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name